What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Visual acuity
His primary areas of study are Ophthalmology, Surgery, Visual acuity, Vitrectomy and Retinal.
Ophthalmology is closely attributed to Retinopathy in his study.
Eye disease, Intraocular pressure, Bevacizumab, Randomized controlled trial and Endophthalmitis are the subjects of his Surgery studies.
In his work, Cornea is strongly intertwined with Silver nitrate, which is a subfield of Bevacizumab.
As part of one scientific family, Gholam A. Peyman deals mainly with the area of Visual acuity, narrowing it down to issues related to the Macular degeneration, and often Intensive care medicine.
His biological study deals with issues like Retina, which deal with fields such as Implant, Anatomy, Immunoperoxidase and Laser.
His most cited work include:
- Photocoagulation Treatment of Proliferative Diabetic Retinopathy: The Second Report of Diabetic Retinopathy Study Findings (500 citations)
- The artificial silicon retina microchip for the treatment of vision loss from retinitis pigmentosa. (417 citations)
- Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis (331 citations)
What are the main themes of his work throughout his whole career to date?
Gholam A. Peyman focuses on Ophthalmology, Surgery, Vitrectomy, Retinal and Retina.
His study in Visual acuity, Retinal detachment, Pars plana, Fluorescein angiography and Intraocular pressure is carried out as part of his studies in Ophthalmology.
Gholam A. Peyman has included themes like Cornea and Toxicity in his Surgery study.
His work investigates the relationship between Toxicity and topics such as Lagomorpha that intersect with problems in Electroretinography.
Specifically, his work in Retinal is concerned with the study of Fundus.
His Retina study combines topics in areas such as Laser and Anatomy.
He most often published in these fields:
- Ophthalmology (46.62%)
- Surgery (30.19%)
- Vitrectomy (18.47%)
What were the highlights of his more recent work (between 2005-2021)?
- Ophthalmology (46.62%)
- Optics (10.57%)
- Visual acuity (13.12%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Ophthalmology, Optics, Visual acuity, Surgery and Retinal.
His Ophthalmology study frequently draws connections between adjacent fields such as Bevacizumab.
In the subject of general Optics, his work in Lens, Focal length, Phoropter and Laser is often linked to Fluidics, thereby combining diverse domains of study.
His Visual acuity study combines topics from a wide range of disciplines, such as Intraocular pressure, Macular degeneration and Glaucoma.
His Surgery research integrates issues from Silver nitrate, Cornea and Uveitis.
The study incorporates disciplines such as Retina and Indocyanine green in addition to Retinal.
Between 2005 and 2021, his most popular works were:
- Testing intravitreal toxicity of bevacizumab (Avastin). (272 citations)
- Mutant Gq/11 Promote Uveal Melanoma Tumorigenesis by Activating YAP (261 citations)
- Inhibition of experimental corneal neovascularisation by bevacizumab (Avastin) (201 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Visual acuity
The scientist’s investigation covers issues in Ophthalmology, Visual acuity, Surgery, Optics and Cornea.
His Ophthalmology study often links to related topics such as Bevacizumab.
Gholam A. Peyman interconnects Intraocular pressure, Refractory and Etiology in the investigation of issues within Visual acuity.
His Surgery study integrates concerns from other disciplines, such as Phosphatidyl choline and Photocoagulation therapy.
His work deals with themes such as Low molecular weight heparin, Chromatography, Silver nitrate and Mean age, which intersect with Cornea.
In his research, Prospective cohort study is intimately related to Retinal detachment, which falls under the overarching field of Vitrectomy.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
